Skip to main content

Table 3 Gleason staging of adenocarcinoma and survivin expression

From: Evaluation of survivin expression in prostate specimens of patients with prostate adenocarcinoma and benign prostate hyperplasia underwent transurethral resection of the prostate or prostatectomy

Gleason stage

Survivin expression (%)

Negative

1+

2+

3+

Total

2

0

4 (57.1)

2 (28.6)

1 (14.3)

7 (7.4)

3

0

3 (42.9)

2 (28.6)

2 (28.6)

7 (7.4)

4

1 (10)

0

7 (70)

2 (20)

10 (10.6)

5

0

3 (27.3)

4 (36.4)

4 (36.4)

11 (11.7)

6

0

1 (9.1)

4 (36.4)

6 (54.5)

11 (11.7)

7

0

2 (10.5)

9 (47.4)

8 (42.1)

19 (20.2)

8

0

1 (6.7)

3 (20)

11 (73.3)

15 (16)

9

0

0

4 (57.1)

3 (42.9)

7 (7.4)

10

0

0

0

7 (100)

7 (7.4)

Total

1 (1.1)

14 (14.9)

35 (37.2)

44 (46.8)

94 (100)